OR WAIT null SECS
© 2022 MJH Life Sciences and Rheumatology Network. All rights reserved.
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
JOHN H HORNBAKER JR MD PA
11110 MEDICAL CAMPUS RD
The tumor necrosis factor α antagonist infliximab has been used for treating patients with uveitis resistant to corticosteroids.